LPA and triple-A syndrome: Based on our observation that the Lp(a) effects also appear linear for AAA, these findings suggest that substantial reductions in Lp(a) levels, irrespective of baseline levels of Lp(a), may translate into clinically meaningful improvements in AAA outcomes.